Novel Microdevices

Novel Microdevices

Private
Baltimore, MarylandHealthcare & Life Scienceshttps://noveldx.com

Last Round

Seed Round

Apr 27, 2026

Total Funding Raised

$23.76M

Company Overview

Novel Microdevices is a diagnostic equipment company that develops a handheld point-of-care medical device designed to facilitate molecular diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

point-of-care testingPOC testingmolecular diagnosticsrapid PCRinfectious disease testingportable PCRdiagnostic cartridgessample-to-answer platformlab-in-a-boxSTI testingrespiratory panelmedical devicerazor and blade modelwomen's healthmicrofluidicsurgent care testingglobal health

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Novel Microdevices Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Novel Microdevices Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Seed RoundApr 27, 2026
GrantJun 10, 2025
VC RoundFeb 18, 2025
Convertible DebtFeb 6, 2025
Follow-on OfferingNov 8, 2024
Grant
Aug 7, 2023

Key People

Founding team and executive leadership

Andrea Pais

Founder And CEO

Founding Team

Joseph Swiader

Advisor To The Chief Executive Officer

Executive Team

Carlos L. Aparicio

COO

Executive Team

Novel Microdevices Investors

Notable investors and investment history

InvestorRounds
CARB-XGrant
NIH RADxFollow-on Offering, Grant
TEDCOSeries A, Grant, Convertible Debt, VC Round, Pre Seed
Maryland Department of CommerceGrant
Old Line Capital PartnersSeries A
Ecphora CapitalSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 27, 2026

    $1M raised in Seed Round.

Novel Microdevices Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Novel Microdevices Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Novel Microdevices's valuation, stock price, and market status.

Firmographic Details

HeadquartersBaltimore, Maryland
Employee Range41
Year Founded2014
Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.